Lupin Gets USFDA Nod For Febuxostat Tablets, Shares Hit 52-Week High For 2nd Day
Lupin Ltd shares traded fresh 52-week high on Friday after the global pharma major on January 18 announced of receiving approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Febuxostat Tablets, 40 ...